*Suven Life Sciences Ltd. | CMP Rs. 310 | M Cap Rs. 3946 Cr | 52 W H/L 310/183*
Result is above expectations
Revenue from Operations came at Rs. 274.3 Cr (37.9% QoQ, 206.4% YoY) vs expectation of Rs. 157.7 Cr, QoQ Rs. 199 Cr, YoY Rs. 89.5 Cr
EBIDTA came at Rs. 110.5 Cr (22.8% QoQ, 352.7% YoY) vs expectation of Rs. 65.5 Cr, QoQ Rs. 90 Cr, YoY Rs. 24.4 Cr
EBITDA Margin came at 40.3% vs expectation of 41.5%, QoQ 45.2%, YoY 27.3%
Adj. PAT came at Rs. 72.3 Cr vs expectation of Rs. 42.7 Cr, QoQ Rs. 57.2 Cr, YoY Rs. 18 Cr
Quarter EPS is Rs. 5.7
Share is trading at P/E of 30x FY20E EPS